Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin/Benzoyl Peroxide Gel vs BenzaClin in Acne Vulgaris
NCT02595034Phase 1Completed
- Start
- Jan 2015
- Primary completion
- Oct 2015
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of clindamycin + benzoyl peroxide in acne vulgaris (3 arms). Primary endpoints: Change in inflammatory lesion count at 10 weeks and Change in non-inflammatory lesion count at 10 weeks. Started Jan 2015; status: completed.
02
Drugs
clindamycin + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02595034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02595034.